The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
locations
of the student body are Arab Israeli
of the student body are women
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Prof. Jackie Schiller’s work in the Rappaport Faculty of Medicine and the Allen and Jewel Prince Center for Neurodegenerative Disorders of the Brain seeks to understand the brain’s largest and most complex structure, the cerebral cortex, and its links to Parkinson’s disease, epilepsy, autism, and more.
The cerebral cortex is responsible for our most basic sensory and motor functions as well as the higher functions of learning, memory, and emotions. Researchers in the Cortical Computation Lab bearing her name focus on how information is processed, changed, and stored in the neurons of the brain’s cortex. Conducting experiments in learning and memory mechanisms, Prof. Schiller and her team use advanced optics, microscopy, and genetic tools to visualize the cortical network at an unprecedented resolution as it learns new tasks.
Recently, Prof. Schiller collaborated with researchers from the Technion’s Andrew and Erna Viterbi Faculty of Electrical Engineering and the Howard Hughes Medical Institute to conduct dexterity experiments with mice. Their findings, published in Neuron, have furthered medical insight into what happens in the cerebral cortex when learning skilled movement such as reaching and grasping for food, and could lead to treatments for dysfunctions of the cortex. She recently published a study in Science describing for the first time how motor information is represented in the fine dendritic processes of the neurons. These findings may have important implications for understanding and treating Parkinson’s disease.
Prof. Schiller earned her bachelor’s, master’s, and doctoral degrees from the Hebrew University of Jerusalem, and conducted postdoctoral research at both the Max Planck Institute for Medical Research in Heidelberg, Germany, and the Mayo Clinic, in Rochester, Minn. She joined the Technion in 2000.
In the future, Prof. Schiller envisions a multidisciplinary brain center that could draw from the Technion’s strengths as a leading engineering research institute, its medical school, and affiliated academic hospitals.
At the Technion, researchers are unraveling the fierce battles our cells wage against viruses, uncovering how gut microbes shift the tide in chronic disease, and revealing the brain’s surprising power to heal broken hearts. From revolutionary dual-target antibodies that outsmart the flu to groundbreaking discoveries in inflammation, these breakthroughs are rewriting the future of medicine — promising lifesaving therapies that arrive faster, hit harder, and change everything.
Even in the face of the tragic events of October 7, Technion researchers have continued their work, breaking new ground in their respective fields and winning awards. Their resilience was recognized with the 85th spot in the Academic Ranking of World Universities and first place in Israeli academia in the Globes 2024 Brand Index, which focused on the relevance to the job market when choosing a university. Industry As the oldest university in Israel, the Technion has a deep history of ties with industry, sending a high percentage of graduates to the most respected multinational companies. Intel opened facilities in…
Prestigious grants from the European Commission’s Horizon Europe program were awarded to two Technion researchers to advance their decade-long research. Each of them will receive €2.5 million ($2.66 million). Coincidentally, both grants will further studies in brain science. Professor Michael Glickman, dean of the Faculty of Biology, was awarded for his work on an innovative model to study Alzheimer’s disease that uses nerve cells derived from human stem cells. His team’s research is based on the hypothesis that impairment of the ubiquitin system, which clears cells of damaged proteins, could lead to the development of Alzheimer’s. The grant will enable…
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.